THE USE OF DEFERIPRONE TO TREAT FRIEDREICH ATAXIA RESULTING FROM INTRACELLULAR MISHANDLING OF IRON

摘要

A therapeutically effective amount of deferiprone or physiologically acceptable salt thereof for the prevention, stabilization, treatment, or reversal of iron-induced FRDA disease in patients resulting from mitochondrial iron-induced damage to preferentially reduce the iron stores in the mitochondria.